GSK plc Sponsored ADRGSK plc Sponsored ADRGSK plc Sponsored ADR

GSK plc Sponsored ADR

No trades
See on Supercharts

GSK plc Sponsored ADR forum


GSK Break to the downside coming this week since an hedge order came in for 4/19 exp.

Entry below $40.51

Trade becomes invalid on any gap and go or around the $40.98 area

GSK jemperil clinical trial forecasted to be complete by end of June. It treats endometrial cancer